67-6

57/93

) Tsuchida N, Kirino Y, Soejima Y, Onodera M, Arai K, Tamura E, Ishikawa T, Kawai T, Uchiyama T, Nomura S, Kobayashi D, Taguri M, Mitsuhashi S, Mizuguchi T, Takata A, Miyake N, Nakajima H, Miyatake S, Matsu-moto N: Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet’s disease. Arthritis Res Ther. 2019; 21: 137.) Yanagi T, Ushijima K, Koga H, Tomomasa T, Tajiri H, Kunisaki R, Isihige T, Yamada H, Arai K, Yoden A, Aomatsu T, Nagata S, Uchida K, Ohtsuka Y, Shimizu T: Tacrolimus for ulcerative colitis in children: a multicenter survey in Japan. Intest Res. 2019; 17: 476-485. 10) Shigemitsu S, Takahashi K, Yazaki K, Kobayashi M, Yamada M, Akimoto K, Tamaichi H, Fujimura J, Saito M, Nii M, Itatani K, Shimizu T: New insight into the intraventricular pressure gradient as a sensi-tive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anth-racycline therapy. Heart Vessels. 2019; 34: 992-1001. 8 9 11) Takahashi K, Nii M, Takigiku K, Toyono M, Iwashima S, Inoue N, Tanaka N, Matsui K, Shigemitsu S, Yamada M, Kobayashi M, Yazaki K, Itatani K, Shimizu T: Development of suction force during early diastole from the left atrium to the left ventricle in infants, children, and adolescents. Heart Vessels, 2019; 34: 296-306. 12) Hagiwara SI, Kudo T, Kakuta F, Inoue M, Yokoyama K, Umetsu S, Iwama I, Yodoshi T, Tatsuki M, Shimizu T, Nakayama Y: Clinical safety and utility of pediatric balloon assisted enteroscopy; A multicenter prospective study in Japan. J Pediatr Gastroenterol Nutr. 2019; 68: 306-310. 13) Iwama I, Shimizu H, Nambu R, Okuhira T, Kakuta F, Tachibana N, Abe N, Honma H, Kudo T, Nakayama Y: Efficacy and safety of a capsule endoscope delivery device in chil-dren. Eur J Gastroenterol Hepatol. 2019; 31: 1502-1507. 14) Konishi KI, Mizuochi T, Yanagi T, Watanabe Y, Ohkubo K, Ohga S, Maruyama H, Takeuchi I, Sekine Y, Masuda K, Kikuchi N, Yotsumoto Y, Ohtsuka Y, Tanaka H, Kudo T, Noguchi A, Fuwa K, Mushiake S, Ida S, Fujishiro J, Yamashita Y, Taguchi T, Yamamoto K: Clin-ical features, molecular genetics, and long-term outcome in congenital chloride diarrhea: A nationwide study in Japan. J Pediatr. 2019; 214: 151-157. 15) Kumagai H, Kudo T, Uchida K, Kunisaki R, Sugita A, Ohtsuka Y, Arai K, Kubota M, Tajiri H, Suzuki Y, Shimizu T: Adult gastro-enterologists’ views on transitional care: Results from a survey. Pediatr Int. 2019; 61: 817-822. 16) Fujinaga S, Gonda Y: Two different clinical aspects of Japanese children with asymptom-atic nephrotic syndrome at onset. Clin Exp Nephrol. 2019; 23: 721-722. 17) Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M: Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine. Pediatr Nephrol. 2019; 34: 2417-2421. 18) Fujinaga S, Kusaba K: Impact of acute kidney injury at the onset of idiopathic nephrotic syndrome in Japanese children. Clin Exp Nephrol. 2019; 23: 1171-1172. 19) Fujinaga S, Nishino T, Umeda C, Tomii Y, Watanabe Y, Sakuraya K: Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2019; 34: 353-357. 20) Fujinaga S, Nishino T: Risk factors for early B cell recovery following single-dose rituximab therapy in Japanese children with steroid-de-pendent nephrotic syndrome. Pediatr Nephrol. 2019; 34: 359-360. 21) Fujinaga S, Sakuraya K: Inhibitory effect of steroid on absorption fever after percuta-neous renal biopsy. Pediatr Int. 2019; 61: 512-513. 22) Fujinaga S, Sakuraya K: Spontaneous femoral artery thrombosis in childhood-onset nephrotic syndrome. Pediatr Int. 2019; 61: 526-527. 23) Fujinaga S, Tomii Y: Predictors of rituximab- related neutropenia in Japanese children with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2019; 34: 1303-1304. 24) Toda K, Hisata K, Satoh T, Katsumata N, Odamaki T, Mitsuyama E, Katayama T, 565